Description of Collaborative Activity: |
Public-private partnership between the National Institutes of Health (NIH), the Food and Drug Administration (FDA), 12 biopharmaceutical companies and multiple non-profit organizations, and managed by the Foundation for NIH (FNIH), to transform the current model for developing new diagnostics and treatments by jointly identifying and validating promising biological targets for therapeutics. |
NIH Participating Institutes/Centers/Office of the Director: |
NIA, NIAMS, NIDDK, NINDS, OD/OSP |
